Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine Continuation in Bipolar I Disorder
NCT00145509Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in bipolar I disorder, sponsored by Organon & Co.. Started Aug 2005; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00145509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145509.